| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | 11,867.00 | -952.74 | -1,393.34 | 1,243.42 |
| Net Changein Cash | 543.72 | -261.66 | 326.61 | 110.13 |
| Cash Taxes Paid | 808.92 | 602.82 | 498.10 | 398.07 |
| Net Income/ Starting Line | 2,872.19 | 2,672.81 | 2,352.11 | 1,847.16 |
| Total Cash Dividends Paid | -1,288.94 | -1,083.03 | -1,015.34 | -863.04 |
| Changesin Working Capital | -1,150.89 | -1,083.75 | -80.02 | -357.44 |
| Cashfrom Operating Activities | 3,022.71 | 2,585.11 | 3,266.08 | 2,426.96 |
| Cash Interest Paid | 427.46 | 262.22 | 370.96 | 303.02 |
| Cashfrom Financing Activities | 10,150.60 | -2,297.99 | -2,779.64 | 77.36 |
| Depreciation/ Depletion | 1,118.87 | 794.93 | 808.27 | 706.59 |
| Other Investing Cash Flow Items Total | -12,035.02 | 71.82 | 264.88 | -1,841.37 |
| Capital Expenditures | -677.39 | -611.87 | -432.78 | -573.94 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 82.82 | -8.73 | 8.07 | 21.12 |
| Non- Cash Items | 182.54 | 201.12 | 185.72 | 230.65 |
| Financing Cash Flow Items | -427.46 | -262.22 | -370.96 | -303.02 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -12,712.41 | -540.05 | -167.90 | -2,415.31 |
Torrent Pharmaceuticals Dividend Torrent Pharmaceuticals Bonus Torrent Pharmaceuticals News Torrent Pharmaceuticals AGM Torrent Pharmaceuticals Rights Torrent Pharmaceuticals Splits Torrent Pharmaceuticals Board Meetings Torrent Pharmaceuticals Key Metrics Torrent Pharmaceuticals Shareholdings Torrent Pharmaceuticals Profit Loss Torrent Pharmaceuticals Balance Sheet Torrent Pharmaceuticals Q1 Results Torrent Pharmaceuticals Q2 Results Torrent Pharmaceuticals Q3 Results Torrent Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.